A T lymphocyte-specific transcription complex containing RUNX1 activates MHC Class I expression

Journal of Immunology

Volumn 174, Issue 4, 2005, Pages 2106-2115

  Howcroft, T Kevin ^a   Weissman, Jocelyn D ^a   Gegonne, Anne ^a   Singer, Dinah S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCEOSOME; LYMPHOID ENHANCER FACTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN ALY; PROTEIN CBF BETA; PROTEIN CIITA; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 13544253730     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.4.2106     Document Type: Article

References (95)

1. van den Eisen, P. J., T. M. Holling, N. van der Stoep, and J. M. Boss. 2003. DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies. Clin. Immunol. 109:46.
2. Girdlestone, J. 1996. Transcriptional regulation of MHC class I genes. Eur. J. Immunogenet. 23:395.
3. Singer, D. S., and J. E. Maguire. 1990. Regulation of the expression of class I MHC genes. Crit. Rev. Immunol. 10:235.
4. Howcroft, T. K., and D. S. Singer. 2003. Expression of nonclassical MHC class Ib genes: comparison of regulatory elements. Immunol. Res. 27:1.
5. Le Bouteiller, P. 1994. HLA class I chromosomal region, genes, and products: facts and questions. Crit. Rev. Immunol. 14:89.
6. Singer, D. S., E. Mozes, S. Kirshner, and L. D. Kohn. 1997. Role of MHC class I molecules in autoimmune disease. Crit. Rev. Immunol. 17:463.
7. Weissman, J. D., and D. S. Singer. 1991. A complex regulatory DNA element associated with a major histocompatibility complex class I gene consists of both a silencer and an enhancer. Mol. Cell. Biol. 11:4217.
8. Girdlestone, J. 2000. Synergistic induction of HLA class 1 expression by RelA and CIITA. Blood 95:3804.
9. Taniguchi, S. I., M. Shong, C. Giuliani, G. Napolitano, M. Saji, V. Montani, K. Suzuki, D. S. Singer, and L. D. Kohn. 1998. Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF-κB. Mol. Endocrinol. 12:19.
10. Gobin, S. J., V. Keijsers, M. van Zutphen, and P. J. van den Elsen. 1998. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor κB. J. Immunol. 161:2276.
11. Giuliani, C., M. Saji, G. Napolitano, L. A. Palmer, S. I. Taniguchi, M. Shong, D. S. Singer, and L. D. Kohn. 1995. Hormonal modulation of major histocompatibility complex class I gene expression involves an enhancer A-binding complex consisting of Fra-2 and the p50 subunit of NF-κB. J. Biol. Chem. 270:11453.
12. Israel, A., O. Le Bail, D. Hatat, J. Piette, M. Kieran, F. Logeat, D. Wallach, M. Fellous, and P. Kourilsky. 1989. TNF stimulates expression of mouse MHC class I genes by inducing an NFκB-like enhancer binding activity which displaces constitutive factors. EMBO J. 8:3793.
13. Blanar, M. A., L. C. Burkly, and R. A. Flavell. 1989. NF-κB binds within a region required for B-cell-specific expression of major histocompatibility complex class II gene Eαd. Mol. Cell. Biol. 9:844.
14. Waring, J. F., J. E. Radford, L. J. Burns, and G. D. Ginder. 1995. The human leukocyte antigen A2 interferon-stimulated response element consensus sequence binds a nuclear factor required for constitutive expression. J. Biol. Chem. 270:12276.
15. Baldwin, A. S., Jr., and P. A. Sharp. 1987. Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene. Mol. Cell. Biol. 7:305.
16. Gobin, S. J., A. Peijnenburg, V. Keijsers, and P. J. van den Elsen. 1997. Site α is crucial for two routes of IFNγ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6:601.
17. Gobin, S. J., M. van Zutphen, A. M. Woltman, and P. J. van den Elsen. 1999. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J. Immunol. 163:1428.
18. Kimura, A., A. Israel, O. Le Bail, and P. Kourilsky. 1986. Detailed analysis of the mouse H-2Kb promoter: enhancer-like sequences and their role in the regulation of class I gene expression. Cell 44:261.
19. Girdlestone, J. 1995. Regulation of HLA class I loci by interferons. Immunobiology 193:229.
20. Martin, B. K., K. C. Chin, J. C. Olsen, C. A. Skinner, A. Dey, K. Ozato, and J. P. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6:591.
21. Raval, A., T. K. Howcroft, J. D. Weissman, S. Kirshner, X. S. Zhu, K. Yokoyama, J. Ting, and D. S. Singer. 2001. Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250. Mol. Cell 7:105.
22. Masternak, K., A. Muhlethaler-Mottet, J. Villard, M. Zufferey, V. Steimle, and W. Reith. 2000. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14:1156.
23. Spilianakis, C., A. Kretsovali, T. Agalioti, T. Makatounakis, D. Thanos, and J. Papamatheakis. 2003. CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II. EMBO J. 22:5125.
24. Jabrane-Ferrat, N., N. Nekrep, G. Tosi, L. Esserman, and B. M. Peterlin. 2003. MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators? Int. Immunol. 15:467.
25. Masternak, K., and W. Reith. 2002. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation. EMBO J. 21:1379.
26. LeibundGut-Landmann, S., J. M. Waldburger, M. Krawczyk, L. A. Otten, T. Suter, A. Fontana, H. Acha-Orbea, and W. Reith. 2004. Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 34:1513.
27. Barseguian, K., B. Lutterbach, S. W. Hiebert, J. Nickerson, J. B. Lian, J. L. Stein, A. J. van Wijnen, and G. S. Stein. 2002. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins. Proc. Natl. Acad. Sci. USA 99:15434.
28. Waldburger, J. M., K. Masternak, A. Muhlethaler-Mottet, J. Villard, M. Peretti, S. Landmann, and W. Reith. 2000. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. Immunol. Rev. 178:148.
29. Boss, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107.
30. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
31. Holling, T., N. van der Stoep, E. Quinten, and P. van den Elsen. 2002. Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III. J. Immunol. 168:763.
32. Holling, T., E. Schooten, and P. van den Elsen. 2004. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum. Immunol. 65:282.
33. Wong, A. W., N. Ghosh, K. McKinnon, W. Reed, J. Piskurich, K. Wright, and J. P. Ting. 2002. Regulation and specificity of MHCT2A promoter usage in human primary T lymphocytes and cell line. J. Immunol. 169:3112.
34. Giese, K., C. Kingsley, J. R. Kirshner, and R. Grosschedl. 1995. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9:995.
35. Sun, W., B. J. Graves, and N. A. Speck. 1995. Transactivation of the Moloney murine leukemia virus and T-cell receptor β-chain enhancers by cbf and ets requires intact binding sites for both proteins. J. Virol. 69:4941.
36. Ho, I. C., L. H. Yang, G. Morle, and J. M. Leiden. 1989. A T-cell-specific transcriptional enhancer element 3′ of Cα in the human T-cell receptor α locus. Proc. Natl. Acad. Sci. USA 86:6714.
37. Mayall, T. P., P. L. Sheridan, M. R. Montminy, and K. A. Jones. 1997. Distinct roles for P-CREB and LEF-1 in TCRα enhancer assembly and activation on chromatin templates in vitro. Genes Dev. 11:887.
38. Halle, J. P., P. Haus-Seuffert, C. Woltering, G. Stelzer, and M. Meisterernst. 1997. A conserved tissue-specific structure at a human T-cell receptor β-chain core promoter. Mol. Cell. Biol. 17:4220.
39. Levanon, D., R. E. Goldstein, Y. Bernstein, H. Tang, D. Goldenberg, S. Stifani, Z. Paroush, and Y. Groner. 1998. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc. Natl. Acad. Sci. USA 95:11590.
40. Bruhn, L., A. Munnerlyn, and R. Grosschedl. 1997. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRa enhancer function. Genes Dev. 11:640.
41. Lund, A. H., and M. van Lohuizen. 2002. RUNX: a trilogy of cancer genes. Cancer Cell. 1:213.
42. Ito, Y. 2004. Oncogenic potential of the RUNX gene family: "overview." Oncogene 23:4198.
43. Durst, K. L., and S. W. Hiebert. 2004. Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 23:4220.
44. Clevers, H. C., and R. Grosschedl. 1996. Transcriptional control of lymphoid development: lessons from gene targeting. Immunol. Today 17:336.
45. de Bruijn, M. F., and N. A. Speck. 2004. Core-binding factors in hematopoiesis and immune function. Oncogene 23:4238.
46. Kurokawa, M., and H. Hirai. 2003. Role of AML1/Runx1 in the pathogenesis of hematological malignancies. Cancer Sci. 94:841.
47. Uchida, H., J. R. Downing, Y. Miyazaki, R. Frank, J. Zhang, and S. D. Nimer. 1999. Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter. Oncogene 18:1015.
48. Bristow, C. A., and P. Shore. 2003. Transcriptional regulation of the human MIP-1α promoter by RUNX1 and MOZ. Nucleic Acids Res. 31:2735.
49. Choi, S. J., T. Oba, N. S. Callander, D. F. Jelinek, and G. D. Roodman. 2003. AML-1A and AML-1B regulation of MIP-1α expression in multiple myeloma. Blood 101:3778.
50. Liu, H., M. Holm, X. Q. Xie, M. Wolf-Watz, and T. Grundstrom. 2004. AML1/Runx1 recruits calcineurin to regulate granulocyte macrophage colony-stimulating factor by Ets1 activation. J. Biol. Chem. 279:29398.
51. Petrovick, M. S., S. W. Hiebert, A. D. Friedman, C. J. Hetherington, D. G. Tenen, and D. E. Zhang. 1998. Multiple functional domains of AML1: PU.1 and C/EBPα synergize with different regions of AML1. Mol. Cell. Biol. 18:3915.
52. Zhang, D. E., C. J. Hetherington, S. Meyers, K. L. Rhoades, C. J. Larson, H. M. Chen, S. W. Hiebert, and D. G. Tenen. 1996. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16:1231.
53. Lutterbach, B., J. J. Westendorf, B. Linggi, S. Isaac, E. Seto, and S. W. Hiebert. 2000. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J. Biol. Chem. 275:651.
54. ARF tumor suppressor. Blood Cells Mol. Dis. 30:177.
55. Telfer, J. C., E. E. Hedblom, M. K. Anderson, M. N. Laurent, and E. V. Rothenberg. 2004. Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes. J. Immunol. 172:4359.
56. Taniuchi, I., M. Osato, T. Egawa, M. J. Sunshine, S. C. Bae, T. Komori, Y. Ito, and D. R. Littman. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111:621.
57. Ichikawa, M., T. Asai, S. Chiba, M. Kurokawa, and S. Ogawa. 2004. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis. Cell Cycle 3:722.
58. Kagoshima, H., K. Shigesada, M. Satake, Y. Ito, H. Miyoshi, M. Ohki, M. Pepling, and P. Gergen. 1993. The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet. 9:338.
59. Yang, X. J. 2004. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res. 32:959.
60. Yamaguchi, Y., M. Kurokawa, Y. Imai, K. Izutsu, T. Asai, M. Ichikawa, G. Yamamoto, E. Nitta, T. Yamagata, K. Sasaki, et al. 2004. AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues. J. Biol. Chem. 279:15630.
61. Travis, A., A. Amsterdam, C. Belanger, and R. Grosschedl. 1991. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor a enhancer function [corrected]. Genes Dev. 5:880.
62. Giese, K., and R. Grosschedl. 1993. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J. 12:4667.
63. Hsu, S. C., J. Galceran, and R. Grosschedl. 1998. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin. Mol. Cell. Biol. 18:4807.
64. Singer, D. S., R. D. Camerini-Otero, M. L. Satz, B. Osborne, D. Sachs, and S. Rudikoff. 1982. Characterization of a porcine genomic clone encoding a major histocompatibility antigen: expression in mouse L cells. Proc. Natl. Acad. Sci. USA 79:1403.
65. Frels, W. I., J. A. Bluestone, R. J. Hodes, M. R. Capecchi, and D. S. Singer. 1985. Expression of a microinjected porcine class I major histocompatibility complex gene in transgenic mice. Science 228:577.
66. Howcroft, T. K., K. Strebel, M. A. Martin, and D. S. Singer. 1993. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260:1320.
67. Lutterbach, B., and S. W. Hiebert. 2000. Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 245:223.
68. Adya, N., T. Stacy, N. A. Speck, and P. P. Liu. 1998. The leukemic protein core binding factor β (CBFβ)-smooth-muscle myosin heavy chain sequesters CBFα2 into cytoskeletal filaments and aggregates. Mol. Cell. Biol. 18:7432.
69. Howcroft, T. K., J. C. Richardson, and D. S. Singer. 1993. MHC class I gene expression is negatively regulated by the proto-oncogene, c-jun. EMBO J. 12:3163.
70. Oberley, M. J., and P. J. Farnham. 2003. Probing chromatin immunoprecipitates with CpG-island microarrays to identify genomic sites occupied by DNA-binding proteins. Methods Enzymol. 371:577.
71. Kirshner, S., L. Palmer, J. Bodor, M. Saji, L. D. Kohn, and D. S. Singer. 2000. Major histocompatibility class I gene transcription in thyrocytes: a series of interacting regulatory DNA sequence elements mediate thyrotropin/cyclic adenosine 3′,5′-monophosphate repression. Mol. Endocrinol. 14:82.
72. Saji, M., M. Shong, G. Napolitano, L. A. Palmer, S. I. Taniguchi, M. Ohmori, M. Ohta, K. Suzuki, S. L. Kirshner, C. Giuliani, D. S. Singer, and L. D. Kohn. 1997. Regulation of major histocompatibility complex class I gene expression in thyroid cells: role of the cAMP response element-like sequence. J. Biol. Chem. 272:20096.
73. Napolitano, G., V. Montant, C. Giuliani, S. Di Vincenzo, I. Bucci, V. Todisco, G. Laglia, A. Coppa, D. S. Singer, M. Nakazato, et al. 2000. Transforming growth factor-β1 down-regulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors. Mol. Endocrinol. 14:486.
74. Burke, P. A., S. Hirschfeld, Y. Shirayoshi, J. W. Kasik, K. Hamada, E. Appella, and K. Ozato. 1989. Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene. J. Exp. Med. 169:1309.
75. Ishizu, A., K. Sawai, H. Ikeda, T. Hirano, N. Ishiguro, and D. Meruelo. 2000. Transduction of a murine dominant negative activation transcription factor 1 increases cell surface expression of the class I MHC on a human epidermoid tumor cell line. Int. Immunol. 12:161.
76. Ishiguro, N., G. D. Brown, and D. Meruelo. 1997. Activation transcription factor 1 involvement in the regulation of murine H-2Dd expression. J. Biol. Chem. 272:15993.
77. Meyers, S., and S. W. Hiebert. 2000. Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia. J. Cell. Biochem. Suppl. 35:93.
78. Tang, L., B. Guo, A. Javed, J. Y. Choi, S. Hiebert, J. B. Lian, A. J. van Wijnen, J. L. Stein, G. S. Stein, and G. W. Zhou. 1999. Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2αB/core binding factor α2. J. Biol. Chem. 274:33580.
79. Zeng, C., A. J. van Wijnen, J. L. Stein, S. Meyers, W. Sun, L. Shopland, J. B. Lawrence, S. Penman, J. B. Lian, G. S. Stein, and S. W. Hiebert. 1997. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-α transcription factors. Proc. Natl. Acad. Sci. USA 94:6746.
80. Thanos, D., and T. Maniatis. 1995. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83:1091.
81. Merika, M., and D. Thanos. 2001. Enhanceosomes. Curr. Opin. Genet. Dev. 11:205.
82. Adya, N., L. H. Castilla, and P. P. Liu. 2000. Function of CBFβ/Bro proteins. Semin. Cell Dev. Biol. 11:361.
83. Wheeler, J. C., K. Shigesada, J. P. Gergen, and Y. Ito. 2000. Mechanisms of transcriptional regulation by Runt domain proteins. Semin. Cell Dev. Biol. 11:369.
84. Sheridan, P. L., C. T. Sheline, K. Cannon, M. L. Voz, M. J. Pazin, J. T. Kadonaga, and K. A. Jones. 1995. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9:2090.
85. Giese, K., J. Cox, and R. Grosschedl. 1992. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69:185.
86. Reith, W., and B. Mach. 2001. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19:331.
87. Lukasik, S. M., L. Zhang, T. Corpora, S. Tomanicek, Y. Li, M. Kundu, K. Hartman, P. P. Liu, T. M. Laue, R. L. Biltonen, N. A. Speck, and J. H. Bushweller. 2002. Altered affinity of CBFβ-SMMHC for Runx1 explains its role in leukemogenesis. Nat. Struct. Biol. 9:674.
88. McNeil, S., C. Zeng, K. S. Harrington, S. Hiebert, J. B. Lian, J. L. Stein, A. J. van Wijnen, and G. S. Stein. 1999. The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFα2 transcription factor. Proc. Natl. Acad. Sci. USA 96:14882.
89. Peterson, L. F., and D. E. Zhang. 2004. The 8;21 translocation in leukemogenesis. Oncogene 23:4255.
90. Okuda, T., Z. Cai, S. Yang, N. Lenny, C. J. Lyu, J. M. van Deursen, H. Harada, and J. R. Downing. 1998. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood 91:3134.
91. Higuchi, M., D. O'Brien, P. Kumaravelu, N. Lenny, E. J. Yeoh, and J. R. Downing. 2002. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell. 1:63.
92. Tokuhiro, S., R. Yamada, X. Chang, A. Suzuki, Y. Kochi, T. Sawada, M. Suzuki, M. Nagasaki, M. Ohtsuki, M. Ono, et al. 2003. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35:341.
93. Coutinho, J. 2004. RUNX1: transcription factor scores a hat-trick of autoimmune diseases. Clin. Genet. 65:180.
94. Singer, D. S., H. Zinger, L. D. Kohn, and E. Mozes. 1999. Differing MHC class I requirements for induction and propagation of experimental systemic lupus erythematosus. Eur. J. Immunol. 29:2259.
95. Mozes, E., L. D. Kohn, F. Hakim, and D. S. Singer. 1993. Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science 261:91.